Case report: Prader-Willi syndrome and inflammatory arthritis-An important consideration.

Prader-Willi syndrome arthritis genetic disorders human growth hormone juvenile Idiopathic arthritis obesity uveitis

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2023
Historique:
received: 18 11 2022
accepted: 20 02 2023
medline: 4 4 2023
entrez: 3 4 2023
pubmed: 4 4 2023
Statut: epublish

Résumé

Prader-Willi syndrome (PWS) is a multisystemic genetically determined disorder. Musculoskeletal manifestations are common in most patients. We report the cases of two children with PWS who developed inflammatory arthritis, complicated with chronic anterior bilateral uveitis in one case. To our knowledge, no previous reports of such an association exist. Case 1 was of a 3-year-old girl diagnosed with PWS who developed arthritis of the right knee with morning stiffness, joint swelling, and limited range of motion. Other causes of arthritis were ruled out. Increased inflammatory markers, antinuclear antibody (ANA) positivity, and hypertrophic synovitis on ultrasound confirmed the diagnosis of inflammatory arthritis compatible with juvenile idiopathic arthritis (JIA). Despite the treatment with methotrexate, arthritis progressed, and etanercept was added. The patient reached and maintained articular remission while on combined MTX and etanercept treatment during 9 years of follow-up. Case 2 was of a 6-year-old boy diagnosed with PWS who developed arthritis of the right knee. Laboratory investigations showed mildly increased acute phase reactants, microcytic anemia, and ANA positivity at high titer (titer 1:1,280). Infectious and other causes of arthritis were excluded. Ultrasound confirmed the presence of joint effusion and synovial thickening, and synovial fluid analysis was consistent with inflammatory arthrosynovitis (white blood cell count of 14,200/µl) compatible with JIA. Shortly after the diagnosis, the ophthalmologic evaluation revealed the presence of bilateral anterior uveitis. Despite MTX and topical corticosteroid, ocular inflammation persisted and adalimumab was added. At the last follow-up, 9 months later, the child experienced inactivity of arthritis and uveitis with normal growth. We aim to raise awareness of this possible association among pediatricians since arthritis might be underestimated due to high pain tolerance, behavioral disturbances, and other musculoskeletal abnormalities in PWS patients.

Sections du résumé

Background UNASSIGNED
Prader-Willi syndrome (PWS) is a multisystemic genetically determined disorder. Musculoskeletal manifestations are common in most patients. We report the cases of two children with PWS who developed inflammatory arthritis, complicated with chronic anterior bilateral uveitis in one case. To our knowledge, no previous reports of such an association exist.
Case presentation UNASSIGNED
Case 1 was of a 3-year-old girl diagnosed with PWS who developed arthritis of the right knee with morning stiffness, joint swelling, and limited range of motion. Other causes of arthritis were ruled out. Increased inflammatory markers, antinuclear antibody (ANA) positivity, and hypertrophic synovitis on ultrasound confirmed the diagnosis of inflammatory arthritis compatible with juvenile idiopathic arthritis (JIA). Despite the treatment with methotrexate, arthritis progressed, and etanercept was added. The patient reached and maintained articular remission while on combined MTX and etanercept treatment during 9 years of follow-up. Case 2 was of a 6-year-old boy diagnosed with PWS who developed arthritis of the right knee. Laboratory investigations showed mildly increased acute phase reactants, microcytic anemia, and ANA positivity at high titer (titer 1:1,280). Infectious and other causes of arthritis were excluded. Ultrasound confirmed the presence of joint effusion and synovial thickening, and synovial fluid analysis was consistent with inflammatory arthrosynovitis (white blood cell count of 14,200/µl) compatible with JIA. Shortly after the diagnosis, the ophthalmologic evaluation revealed the presence of bilateral anterior uveitis. Despite MTX and topical corticosteroid, ocular inflammation persisted and adalimumab was added. At the last follow-up, 9 months later, the child experienced inactivity of arthritis and uveitis with normal growth.
Conclusions UNASSIGNED
We aim to raise awareness of this possible association among pediatricians since arthritis might be underestimated due to high pain tolerance, behavioral disturbances, and other musculoskeletal abnormalities in PWS patients.

Identifiants

pubmed: 37009284
doi: 10.3389/fped.2023.1102382
pmc: PMC10063871
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1102382

Informations de copyright

© 2023 Marelli, Dallos, Miserocchi, Nucci, Tombolini, Lucia, Gattinara, Caporali and Marino.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Rheumatol. 2018 Aug;45(8):1173-1179
pubmed: 29961686
Arthritis Care Res (Hoboken). 2021 Dec;73(12):1739-1745
pubmed: 33242376
Ocul Immunol Inflamm. 2015 Feb;23(1):74-81
pubmed: 24329729
RMD Open. 2019 Jun 3;5(1):e000890
pubmed: 31245048
Front Pharmacol. 2019 Jun 12;10:637
pubmed: 31249526
Curr Rheumatol Rep. 2000 Apr;2(2):175-80
pubmed: 11123056
Diagnostics (Basel). 2022 Dec 27;13(1):
pubmed: 36611367
J Pediatr. 2020 Mar;218:228-230.e1
pubmed: 31748120
Trends Genet. 1998 May;14(5):194-200
pubmed: 9613204
Res Dev Disabil. 2011 Sep-Oct;32(5):1722-8
pubmed: 21454046
Int J Rheum Dis. 2017 Nov;20(11):1785-1787
pubmed: 26178174
BMC Ophthalmol. 2021 Aug 12;21(1):296
pubmed: 34380467
Ocul Immunol Inflamm. 2013 Jun;21(3):180-91
pubmed: 23713827
Clin Immunol. 2020 Feb;211:108322
pubmed: 31830532
J Rheumatol. 2004 Feb;31(2):390-2
pubmed: 14760812
Pediatrics. 2001 Nov;108(5):E92
pubmed: 11694676
Curr Pediatr Rev. 2019;15(4):207-244
pubmed: 31333129
J Pediatr Orthop. 2010 Jun;30(4):390-5
pubmed: 20502241
Clin Exp Rheumatol. 2018 Sep-Oct;36(5):929-933
pubmed: 30148444
J Clin Med. 2021 Aug 31;10(17):
pubmed: 34501396

Auteurs

Luca Marelli (L)

Eye Clinic San Giuseppe Hospital, IRCCS Multimedica Scientific Institute, Milan, Italy.

Tomáš Dallos (T)

Second Department of Pediatrics, Comenius University Medical School, Bratislava, Slovakia.

Elisabetta Miserocchi (E)

School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Division of Head and Neck, Ophthalmology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Paolo Nucci (P)

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.

Beatrice Tombolini (B)

School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Division of Head and Neck, Ophthalmology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Orazio De Lucia (O)

Division of Clinical Rheumatology, ASST G.Pini-CTO, Milano, Italy.

Maurizio Gattinara (M)

Unit of Pediatric Rheumatology, ASST G.Pini-CTO, Milan, Italy.

Roberto Caporali (R)

Division of Clinical Rheumatology, ASST G.Pini-CTO, Milano, Italy.
Unit of Pediatric Rheumatology, ASST G.Pini-CTO, Milan, Italy.
Department of Clinical Sciences and Community Health and Research Center for Pediatric and Adult Rheumatic Diseases (RECAP.RD), University of Milan, Milan, Italy.

Achille Marino (A)

Unit of Pediatric Rheumatology, ASST G.Pini-CTO, Milan, Italy.

Classifications MeSH